Think Global Health | Ukraine keeps HIV response steady under fire - European AIDS Treatment Group
This story deserves to be shared
Send it to someone who'd care, or post it on your networks.
War has strained Ukraine’s HIV programs, but capacity built years earlier has kept most prevention and treatment in place.
AccessAdvocacyEpidemiologyHIV ResponseKey PopulationsOctober 11, 2026Think Global Health analysis Ukraine’s HIV response has weathered four and a half years of war, largely on the strength of decisions that its health ministry and civil society organizations made before the war began in 2022. Since then, roughly 1 in 10 health facilities have been damaged or destroyed, 15 million people have been displaced, and 60% of the national budget has been swallowed by defense, but Ukraine hasn’t lost control of one of the region’s worst HIV epidemics. Officially registered new infections fell from 15,360 in 2021 [PDF] to just over 8,000 in 2025 [PDF] — a decline that partly reflects lost territory, emigration, and thinner testing in the southeast — while testing volumes nationally climbed by more than 40% during that period. Coverage of key populations has also remained relatively stable from 2022 to 2026. The number of people receiving PrEP services at least once annually has more than doubled.
This article is an excerpt. To read the full content, visit the original source. European AIDS Treatment Group
Related articles
Continuous glucose monitors help type 2 diabetes patients spend 5 more hours a day in healthy blood sugar range - Medical Xpress
Continuous glucose monitors (CGMs) could transform diabetes management for millions of Americans with type 2 diabetes who don't take insulin, according to findings published in the New England Journal of Medicine. The clinical trial found that adults using CGMs spent approximately five additional hours each day within their target blood sugar range compared with those receiving routine care. Nearly twice as many CGM users also achieved an A1c level below 7%, a common treatment goal for people with diabetes.
Wearing headphones during surgery may reduce nausea and vomiting afterward - Medical Xpress
Patients who wore noise-canceling headphones during minimally invasive gynecological surgery were significantly less likely to experience postoperative nausea and vomiting (PONV), suggest findings from a randomized clinical trial presented at the Anesthesiology 2026 annual meeting.
Kefah Mokbel: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? - Oncodaily
“Beyond Detecting Cancer Recurrence: Can Whole-Genome Sequencing-Based ctDNA Monitoring Help Personalize Adjuvant Treatment? An exciting new study published in The Oncologist highlights the clinical potential of Signatera Genome, a whole-genome sequencing (WGS)-based, tumor-informed circulating tumor DNA (ctDNA) assay, not only for detecting molecular residual disease (MRD), but also for potentially informing adjuvant treatment decisions.
0 comments
No comments yet. Be the first to share your thoughts!